EPRX

SetupConviction 69LongHealthcareScan · Mon, Sep 28, 2026

Bull flagchannel

Eupraxia Pharmaceuticals Inc. (EPRX) closed at $8.22 (+2.56%) on Sep 28, 2026. It is in the "Setting up" lane with a bull flag pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 57, RS Rating 86, -9.4% from its 52-week high, +8.5% year to date. Sector: Healthcare · Biotechnology.

EPRX$8.22+2.56%

ResistanceSupportVol 14

Vol MA14 470.58K

Jun 30Jul 17Aug 5Aug 21Sep 10Sep 28

Trade plan

LongReward : Risk1.51

Entry

8.77

Risk

Stop

8.15

-7.0% to stop

Reward

Target 1

9.70

+10.6% to target

Stretch

Target 2

10.63

+21.2% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

EUPRAXIA PHARMACEUTICALS INC.Biotechnologywww.eupraxiapharma.com ↗

Price8.22

Change+2.56%

Gap-0.75%

Rel volume0.81×

Avg volume607.92K

Avg $ vol4.95M

SMA 207.99

SMA 507.17

SMA 2007.29

Price vs 50+14.50%

Price vs 200+12.63%

MA stackmixed

50/200 cross—

Supertrendup · 7.48

RSI (14)57

MACD hist-0.05

MACD crossbear · 2d

Stoch %K / %D40 / 38

ADX (14)23

+DI / −DI24 / 19

RSI divergence—

MACD divergenceBearish

ATR %5.00%

ADR %5.40%

52w high9.07

52w low5.33

From 52w high-9.43%

Above 52w low+54.13%

New 52w highNo

SqueezeOff

Bollinger width30.49%

%B0.59

Donchian pos77.25%

Donchian high8.77

Donchian low6.33

AVWAP (52w high)7.26

vs AVWAP high+13.15%

AVWAP (52w low)7.23

vs AVWAP low+13.68%

OBV trendUp

Chaikin MF (20)0.30

Today vs 20d0.81×

Avg vol (14d)470.57K

Avg vol (20d)607.92K

Avg $ vol (20d)4.95M

Market cap536.66M

RS Rating86 / 99

RS 3m (vs SPY)+21.35%

RS 6m (vs SPY)+1.52%

RS line new highNo

Trend template6/8

Technical rank85.7

1 week-4.92%

1 month+11.62%

3 months+24.66%

6 months+22.25%

1 year+42.62%

YTD+8.52%

P/E—

P/B6.54

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current15.12

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target17.00

Target upside106.96%

Analyst ratingBuy

Institutional37.63%

Ent. value456.1M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out65.02M

Employees49

ListedWed, Jun 9, 2021

Free float49.6M

Float %83.3%

Short interest7.11M

Days to cover18.4d

Short volume61.7%

Squeeze score68 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.23 vs −$0.25

Last surprise+8.0% beat

Setup gradeB

Conviction69 / 100

Pattern quality92%

Tech rank85.7 / 100

Group rank50 / 100

Status laneSetting up

Setup directionLong

Pattern familyChannel

Resistance8.77

Support7.84

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in EPRX

All disclosures →

No recent disclosed trades by Congress in EPRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EPRX

No recent insider (Form 4) filings in EPRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EPRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

EPRX

Trade plan

Recent news

Get daily signals & real-time alerts.